Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ulinastatin Improves Post-Cardiac Surgery Cognitive Dysfunction by Inhibiting Glycocalyx Degradation: An Observational Study

NCT06268249 is registered in ClinicalTrials.gov with Qin Zhang as lead sponsor.

NCT NCT06268249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06268249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ulinastatin Improves Post-Cardiac Surgery Cognitive Dysfunction by Inhibiting Glycocalyx Degradation: An Observational Study
Lead sponsor
Qin Zhang
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
December 30, 2023
Enrollment
7,065 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative cognitive dysfunction, postoperative delirium